DrugPatentWatch Database Preview
Profile for European Patent Office Patent: 1923053
US Patent Family Members and Approved Drugs for European Patent Office Patent: 1923053
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Try a Free Trial | Mar 25, 2028 | Novartis | TASIGNA | nilotinib hydrochloride monohydrate |
➤ Try a Free Trial | Jan 18, 2027 | Novartis | TASIGNA | nilotinib hydrochloride monohydrate |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |